Cell Kinetics Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cell Kinetics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cell Kinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cell Kinetics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Cell |
Cell Kinetics Relative Risk vs. Return Landscape
If you would invest (100.00) in Cell Kinetics on October 15, 2025 and sell it today you would earn a total of 100.00 from holding Cell Kinetics or generate -100.0% return on investment over 90 days. Cell Kinetics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Cell, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cell Kinetics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cell Kinetics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cell Kinetics, and traders can use it to determine the average amount a Cell Kinetics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CKNTF |
Based on monthly moving average Cell Kinetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cell Kinetics by adding Cell Kinetics to a well-diversified portfolio.
Cell Kinetics Fundamentals Growth
Cell Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cell Kinetics, and Cell Kinetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cell Pink Sheet performance.
| Return On Equity | -1.5 | |||
| Return On Asset | -0.47 | |||
| Operating Margin | (114.43) % | |||
| Current Valuation | 940 K | |||
| Price To Book | 0.09 X | |||
| Price To Sales | 4.76 X | |||
| Revenue | 21 K | |||
| EBITDA | (2.38 M) | |||
| Cash And Equivalents | 4 K | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (2.27 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 3.49 M | |||
| Retained Earnings | (62.93 M) | |||
| Current Asset | 1.06 M | |||
| Current Liabilities | 268 K | |||
Things to note about Cell Kinetics performance evaluation
Checking the ongoing alerts about Cell Kinetics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cell Kinetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cell Kinetics is not yet fully synchronised with the market data | |
| Cell Kinetics has some characteristics of a very speculative penny stock | |
| Cell Kinetics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 21 K. Net Loss for the year was (2.38 M) with profit before overhead, payroll, taxes, and interest of 7 K. | |
| Cell Kinetics has accumulated about 4 K in cash with (2.27 M) of positive cash flow from operations. |
- Analyzing Cell Kinetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cell Kinetics' stock is overvalued or undervalued compared to its peers.
- Examining Cell Kinetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cell Kinetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cell Kinetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cell Kinetics' pink sheet. These opinions can provide insight into Cell Kinetics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Cell Pink Sheet
If you are still planning to invest in Cell Kinetics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cell Kinetics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |